Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI

BACKGROUND: The gold standard of assessing liver fibrosis is liver biopsy, which is invasive and not without risk. Therefore, searching for noninvasive serologic biomarkers for liver fibrosis is an importantly clinical issue. METHODS: A total of 16 healthy volunteers and 45 patients with chronic hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Ai-Sheng, Cheng, Chun-Chia, Lee, Shui-Cheng, Liu, Meng-Lun, Lee, Jing-Ying, Wang, Wen-Ming, Wang, Chia-Chi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914022/
https://www.ncbi.nlm.nih.gov/pubmed/20630109
http://dx.doi.org/10.1186/1423-0127-17-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914022/
https://www.ncbi.nlm.nih.gov/pubmed/20630109
http://dx.doi.org/10.1186/1423-0127-17-58

Ejemplares similares